Akero Therapeutics (AKRO) had the highest return between August 1, 2022 and September 30, 2022 by a mid-cap US stock, returning 227.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Akero Therapeutics (AKRO) | 8/1/2022 - 9/30/2022 | 227.72% |
Rhythm Pharmaceuticals (RYTM) | 8/1/2022 - 9/30/2022 | 96.79% |
Verona Pharma PLC ADR (VRNA) | 8/1/2022 - 9/30/2022 | 80.25% |
Xometry (XMTR) | 8/1/2022 - 9/30/2022 | 51.32% |
Bausch Health Companies (BHC) | 8/1/2022 - 9/30/2022 | 49.13% |
International Seaways (INSW) | 8/1/2022 - 9/30/2022 | 47.9% |
Genius Sports (GENI) | 8/1/2022 - 9/30/2022 | 43.92% |
Weatherford International (WFRD) | 8/1/2022 - 9/30/2022 | 42.88% |
Penumbra (PEN) | 8/1/2022 - 9/30/2022 | 38.27% |
Enovix (ENVX) | 8/1/2022 - 9/30/2022 | 37.86% |
Immunovant (IMVT) | 8/1/2022 - 9/30/2022 | 37.78% |
Palomar (PLMR) | 8/1/2022 - 9/30/2022 | 36% |
Nuvalent (NUVL) | 8/1/2022 - 9/30/2022 | 33.42% |
Agios Pharm (AGIO) | 8/1/2022 - 9/30/2022 | 33.15% |
Wix (WIX) | 8/1/2022 - 9/30/2022 | 32.55% |
Clearwater Analytics (CWAN) | 8/1/2022 - 9/30/2022 | 32.2% |
Kiniksa Pharmaceuticals (KNSA) | 8/1/2022 - 9/30/2022 | 31.56% |
PureCycle Technologies (PCTTW) | 8/1/2022 - 9/30/2022 | 30.77% |
Immunitybio (IBRX) | 8/1/2022 - 9/30/2022 | 30.45% |
Melco Resorts & Entertainment (MLCO) | 8/1/2022 - 9/30/2022 | 29.24% |
Zeta Global (ZETA) | 8/1/2022 - 9/30/2022 | 29.1% |
Recursion Pharmaceuticals (RXRX) | 8/1/2022 - 9/30/2022 | 28.81% |
Torm PLC Class A (TRMD) | 8/1/2022 - 9/30/2022 | 25.91% |
Catalyst Pharmaceuticals (CPRX) | 8/1/2022 - 9/30/2022 | 25.78% |
MoonLake Immunotherapeutics (MLTX) | 8/1/2022 - 9/30/2022 | 25.57% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
